We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Scios, a subsidiary of Johnson & Johnson (J&J), was cited by the FDA’s Division of Drug Marketing, Advertising and Communication (DDMAC) for disseminating promotional materials for congestive heart failure treatment Natrecor without including the requisite indication and safety information.